Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death

Lapo Alinari, Emilia Mahoney, John Patton, Xiaoli Zhang, Lenguyen Huynh, Christian T. Earl, Rajeswaran Mani, Yicheng Mao, Bo Yu, Carl Quinion, William H. Towns, Ching-Shih Chen, David M. Goldenberg, Kristie A. Blum, John C. Byrd, Natarajan Muthusamy, Mette Prætorius-Ibba, Robert A. Baiocchi

Blood (2011) 118 (26): 6893–6903.

https://doi.org/10.1182/blood-2011-06-363879

Published: 2011

Includes: Multimedia, Supplemental data

Journal Articles

FTY720 Increases CD74 Expression and Sensitizes Mantle Cell Lymphoma Cells to Milatuzumab-Mediated Cell Death

Lapo Alinari, MD., Ph.D., Emilia Mahoney, MD, PhD, John T. Patton, Xiaoli Zhang, PhD, MS, Lenguyen Huynh, Christian Tyler Earl, Rajeswaran Mani, DVM, Yicheng Mao, Bo Yu, Ph.D., William H. Towns, Ching-Shih Chen, Ph.D, David M. Goldenberg, Kristie A. Blum, MD, John C. Byrd, MD, Natarajan Muthusamy, DVM, Ph.D, Mette Ibba, PhD, Robert A. Baiocchi, M.D., Ph.D.

Blood (2011) 118 (21): 600.

https://doi.org/10.1182/blood.V118.21.600.600

Published: 2011

Journal Articles

Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-κB–dependent DNA methyltransferase activity in acute myeloid leukemia

Blood (2008) 111 (4): 2364–2373.

https://doi.org/10.1182/blood-2007-08-110171

Published: 2008

Journal Articles

Final Results of a Dose Escalation Study of Flavopiridol in Acute Leukemias Using a Novel Treatment Schedule.

William Blum, MD, Rebecca B. Klisovic, MD, Amy Johnson, PhD, Cheryl Kefauver, RN, Mitch Phelps, PhD, David Lucas, PhD, Lenguyen Huynh, Shujun Liu, PhD, James T. Dalton, PhD, Michael R. Grever, MD, Guido Marcucci, MD, John C. Byrd, MD

Blood (2007) 110 (11): 890.

https://doi.org/10.1182/blood.V110.11.890.890

Published: 2007

Journal Articles

Characterization of HDACI OSU42 as a Novel Histone Deacetylase Inhibitor in AML Cell Lines.

Jin Sun, PhD, Shujun Liu, PhD, Jianhua Yu, PhD, Min Wei, BS, Charlene Mao, PhD, Haiming Ding, PhD, Jessica Kearney, BS, LeNguyen Huynh, MS, Peter Paschka, MD, Dachun Wang, PhD, Rebecca B. Klisovic, MD, Danilo Perrotti, PhD, Ching-shih Chen, PhD, Williom George Blum, MD, Guido Marcucci, MD

Blood (2006) 108 (11): 1988.

https://doi.org/10.1182/blood.V108.11.1988.1988

Published: 2006

Journal Articles

Updated Results of a Phase I Study of Flavopiridol in Acute Leukemias Using a Novel, Pharmacokinetically Derived Schedule: Clinical Activity Including Hyperacute Tumor Lysis Syndrome (TLS), Pharmacokinetics (PK), and Pharmacodynamics (PD).

William Blum, MD, Rebecca B. Klisovic, MD, Cheryl Kefauver, RN, Amy Johnson, PHD, Mitch Phelps, James T. Dalton, David Lucas, PHD, LeNguyen Huynh, Shujun Liu, Michael R. Grever, MD, A.D. Colevas, Guido Marcucci, MD, John C. Byrd, MD

Blood (2006) 108 (11): 4578.

https://doi.org/10.1182/blood.V108.11.4578.4578

Published: 2006

Journal Articles

Bortezomib-Induced Down-Regulation of KIT Is Mediated by Inhibition of Sp1 and NF- k B in AML1/ETO-Positive Cells.

Shujun Liu, PhD, Jiuxia Pang, Jianhua Yu, Ph.D., Zhongfa Liu, Ph.D., Lenguyen Huynh, Jessica Kearney, Peter Paschka, M.D., Rebecca B. Klisovic, M.D., Robert Baiocchi, M.D., William Blum, M.D., Danilo Perrotti, Ph.D., Guido Marcucci, M.D.

Blood (2006) 108 (11): 4211.

https://doi.org/10.1182/blood.V108.11.4211.4211

Published: 2006

Journal Articles

Phase I Study of Low Dose Decitabine in Patients with Acute Myeloid Leukemia (AML): Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity.

William Blum, MD, Rebecca Bruner-Klisovic, MD, Shujun Liu, PhD, John C. Byrd, MD, Zhongfa Liu, PhD, Kenneth K. Chan, PhD, Cheryl Kefauver, R.N., Lenguyen Huynh, Michael R. Grever, MD, Guido Marcucci, MD

Blood (2005) 106 (11): 1861.

https://doi.org/10.1182/blood.V106.11.1861.1861

Published: 2005

NARROW

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death

FTY720 Increases CD74 Expression and Sensitizes Mantle Cell Lymphoma Cells to Milatuzumab-Mediated Cell Death

Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-κB–dependent DNA methyltransferase activity in acute myeloid leukemia

Final Results of a Dose Escalation Study of Flavopiridol in Acute Leukemias Using a Novel Treatment Schedule.

Characterization of HDACI OSU42 as a Novel Histone Deacetylase Inhibitor in AML Cell Lines.

Updated Results of a Phase I Study of Flavopiridol in Acute Leukemias Using a Novel, Pharmacokinetically Derived Schedule: Clinical Activity Including Hyperacute Tumor Lysis Syndrome (TLS), Pharmacokinetics (PK), and Pharmacodynamics (PD).

Bortezomib-Induced Down-Regulation of KIT Is Mediated by Inhibition of Sp1 and NF- k B in AML1/ETO-Positive Cells.

Phase I Study of Low Dose Decitabine in Patients with Acute Myeloid Leukemia (AML): Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only